A qualitative study exploring parents' experiences with epinephrine use for their child's anaphylactic reaction. Issue 1 (18th October 2018)

• Record Type: Journal Article
• Authors: Chooniedass, Rishma; Temple, Beverley; Martin, Donna; Becker, Allan
• Is Part Of: Clinical and translational allergy. Volume 8:Issue 1(2018)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2018-10-18
• Subjects: Anaphylaxis -- Epinephrine -- Food allergy -- Barriers -- Education -- Management; Allergy -- Periodicals; Immunology -- Periodicals; Allergy and Immunology -- Periodicals; Hypersensitivity -- Periodicals; Immune System Phenomena -- Periodicals; 616.97005
• DOI: 10.1186/s13601-018-0230-y
• Languages: English
• ISSNs: 2045-7022

Abstract

Abstract: Background: Children with life threatening food allergies live with the constant threat of a fatal reaction, and caregivers must always be prepared to treat with an epinephrine auto‐injector (EAI). This interpretive phenomenological study explored parents' perceptions and lived experiences with prescribed EAI use for their child. Methods: The purposive sample included ten parents of five children under 12 years of age, diagnosed with a food allergy and prescribed with an EAI who recently experienced anaphylaxis. Data sources included digitally‐recorded semi‐structured interviews and a reflexive journal. Results: Eight main themes emerged: perception of anaphylaxis, life challenges, isolation, anxiety, hesitation, guilt, influence of health care professionals, and lessons learned. Parents uniformly described multiple life challenges and feelings of isolation, anxiety and hesitation during a reaction that lead to subsequent guilt. Conclusions: Handling reactions correctly provided parents with confidence to treat subsequent reactions. Witnessing the effects of an EAI and receiving positive feedback from health care providers further strengthened their confidence to quickly and competently intervene in future reactions.